HomeCompareNLOP vs CAH

NLOP vs CAH: Dividend Comparison 2026

NLOP yields 197.79% · CAH yields 0.99%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NLOP wins by $111.92M in total portfolio value
10 years
NLOP
NLOP
● Live price
197.79%
Share price
$11.30
Annual div
$22.35
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$111.94M
Annual income
$56,120,699.27
Full NLOP calculator →
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →

Portfolio growth — NLOP vs CAH

📍 NLOP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNLOPCAH
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NLOP + CAH cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NLOP pays
CAH pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NLOP
Annual income on $10K today (after 15% tax)
$16,811.95/yr
After 10yr DRIP, annual income (after tax)
$47,702,594.38/yr
CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
At 15% tax rate, NLOP beats the other by $47,702,437.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NLOP + CAH for your $10,000?

NLOP: 50%CAH: 50%
100% CAH50/50100% NLOP
Portfolio after 10yr
$55.98M
Annual income
$28,060,442.16/yr
Blended yield
50.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CAH right now

NLOP
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$73.00
+546.0% upside vs current
Range: $73.00 — $73.00
Altman Z
-0.9
Piotroski
5/9
CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NLOP buys
0
CAH buys
0
No recent congressional trades found for NLOP or CAH in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNLOPCAH
Forward yield197.79%0.99%
Annual dividend / share$22.35$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%5.6%
Portfolio after 10y$111.94M$21.6K
Annual income after 10y$56,120,699.27$185.04
Total dividends collected$105.42M$1.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$73.00$252.33

Year-by-year: NLOP vs CAH ($10,000, DRIP)

YearNLOP PortfolioNLOP Income/yrCAH PortfolioCAH Income/yrGap
1← crossover$30,479$19,778.76$10,804$104.30+$19.7KNLOP
2$88,952$56,339.45$11,672$111.21+$77.3KNLOP
3$248,847$153,668.87$12,607$118.57+$236.2KNLOP
4$668,039$401,772.81$13,616$126.40+$654.4KNLOP
5$1,722,815$1,008,012.72$14,704$134.73+$1.71MNLOP
6$4,272,922$2,429,510.56$15,877$143.59+$4.26MNLOP
7$10,203,492$5,631,465.45$17,142$153.02+$10.19MNLOP
8$23,485,601$12,567,864.41$18,504$163.04+$23.47MNLOP
9$52,164,853$27,035,259.74$19,973$173.70+$52.14MNLOP
10$111,937,092$56,120,699.27$21,557$185.04+$111.92MNLOP

NLOP vs CAH: Complete Analysis 2026

NLOPStock

Net Lease Office Properties (NYSE: NLOP) is a publicly traded real estate investment trust with a portfolio of 59 high-quality office properties, totaling approximately 8.7 million leasable square feet primarily leased to corporate tenants on a single-tenant net lease basis. The vast majority of the office properties owned by NLOP are located in the U.S., with the balance in Europe. The portfolio consists of 62 corporate tenants operating in a variety of industries, generating annualized based rent (ABR) of approximately $145 million. NLOP's business plan is to focus on realizing value for its shareholders primarily through strategic asset management and disposition of its property portfolio over time. Given WPC's extensive knowledge of the portfolio, NLOP is externally managed and advised by wholly owned affiliates of WPC to successfully execute on its business strategy. Over the course of its 50-year history, WPC has developed significant expertise in the single-tenant office real estate sector, including the operation, leasing, acquisition and development of assets through many market cycles, and has a proven track record of execution.

Full NLOP Calculator →

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →
📬

Get this NLOP vs CAH comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NLOP vs SCHDNLOP vs JEPINLOP vs ONLOP vs KONLOP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.